Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―

Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Rep
Asıl Yazarlar: Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Japanese Circulation Society 2019
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://ncbi.nlm.nih.gov/pubmed/33693148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0034
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller